Ropeginterferon for Treatment Free Remission

Clinical trial NCT07105319 · COMPLETED

Trial details

NCT number: NCT07105319
Sponsor: Dong-Wook Kim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

CML (Chronic Myelogenous Leukemia)

Start date: 2021-11-30
Primary completion: 2025-07-30
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.